Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Feb 22, 2015 11:10am
121 Views
Post# 23452443

RE:RE:INTERESTING ARTICLE RE cholesterol EFFLUX AS MEASURE OF HDL

RE:RE:INTERESTING ARTICLE RE cholesterol EFFLUX AS MEASURE OF HDL Hey Jkj.

I think I replied to this before but this is remarkable and bodes well for rvx-208 and the underlying reason perhaps as to why it reduces MACE. Nice to see reinforcement from independent research.

Your detective work is remarkable.

There is an organization called Hypertension Canada. Their main focus seems to be vetting and sponsoring research related to hypertension (high blood pressure) issues. They review many research papers every year and then distill them into what they call the CHEP which stands for the Canadian Hypertension Education Program and it is directed at cardiologists, family doctors, nurses, dieticians, pharmacists and other health care providers. I have looked at some of the research papers but don't have the time to review them re rvx-208. It may be a valuable source of rvx-208 related insight.

Thanks again for your valuable detective work.
Cheers
Toinv   :)
Bullboard Posts